Project DUPIMORPH

Basic data

Title:
DUPIMORPH
Duration:
21/05/2020 to 30/06/2023
Abstract / short description:
A randomized, placebo-controlled phase IIa clinical trial to evaluate the efficacy and safety of subcutaneous Dupilumab in localized scleroderma
Keywords:
psoriasis therapeutics
Psoriasis Therapeutika

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Köln, Nordrhein-Westfalen, Germany
Help

will be deleted permanently. This cannot be undone.